Race for a lifeline: experimental drug trial targets deadly childhood brain cancer
NCT ID NCT02887040
Summary
This study is for people newly diagnosed with a rare and aggressive brainstem tumor called diffuse intrinsic pontine glioma (DIPG). It will test if adding an experimental drug combination called antineoplastons to standard radiation therapy helps patients live longer than radiation alone. The trial will enroll about 92 children and adults to compare survival and side effects between the two treatment approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN STEM GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.